重复的低水平红光疗法对近视控制和胸膜治疗的影响
Ying Liu1, Mengxia Zhu1, Xiaoqin Yan1
1Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Translational vision science & technology
|October 21, 2024
概括
重复的低水平红光 (RLRL) 疗法通过改善轴长和球形等效来显示显著的近视控制. 这种疗法还增强了胆管循环,表明其作为有效的近视管理策略的潜力.
科学领域:
- 眼科医生 眼科 眼科
- 生物医学工程 生物医学工程
- 视觉科学 视觉科学 视觉科学
背景情况:
- 近视是一种常见的折射误差,构成了重大的公共卫生挑战.
- 目前的近视控制策略存在局限性,需要新的治疗方法.
- 了解基于光疗法对眼睛的影响对于开发有效干预措施至关重要.
研究的目的:
- 评估重复的低水平红光 (RLRL) 治疗对关键近视指标的长期影响:轴长 (AL) 和球形等效 (SE).
- 评估RLRL治疗对心脏状元参数的影响,包括心脏状元厚度 (CT),心脏状元血管度 (CV) 和心脏状元膜光线区域 (CLA).
主要方法:
- 一项涉及208个近视眼睛的研究,分为RLRL治疗组 (100只眼睛) 和对照组 (108只眼睛).
- 对这两组人群进行一年的随访,以监测AL和SE的变化.
- 在RLRL组进行胆管成像,以评估CT,CV和CLA治疗前后.
主要成果:
- RLRL组在3个月和6个月后显示AL的下降,在12个月后恢复到基线,而对照组在一年内显示AL的显著增加.
- 在随访期间,RLRL组的SE显著增加,与对照组的下降形成鲜明对比.
- 在RLRL组中观察到CT,CV和CLA的显著改善,这些胆道变化与AL/SE修饰之间有很强的相关性.
结论:
- RLRL治疗有效地改善了冠状腺血液输液和血液循环,这可能解释了观察到的近视进展调节.
- 这项研究表明RLRL治疗是一种有前途的近视控制新方法.
- 对RLRL治疗的短期反应可以预测长期结果,有助于治疗疗效的评估.
相关概念视频
01:16Focusing of Light in the Eye
2.5K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
2.5K
01:27Open Angle Glaucoma: Treatment
397
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
397